Literature DB >> 21988964

Mysteries about drug metabolism in the obese weigh on doctors.

Alisa Opar.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21988964     DOI： 10.1038/nm1011-1158a

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  4 in total

Review 1.  Pharmacokinetic considerations in the obese.

Authors:  Yigal Leykin; Linda Miotto; Tommaso Pellis
Journal:  Best Pract Res Clin Anaesthesiol       Date:  2011-03

Review 2.  Implications of obesity for drug therapy: limitations and challenges.

Authors:  R Jain; S M Chung; L Jain; M Khurana; S W J Lau; J E Lee; J Vaidyanathan; I Zadezensky; S Choe; C G Sahajwalla
Journal:  Clin Pharmacol Ther       Date:  2011-06-01       Impact factor: 6.875

3.  Pharmacokinetics of intravenous levofloxacin administered at 750 milligrams in obese adults.

Authors:  Aaron M Cook; Craig Martin; Val R Adams; R Scott Morehead
Journal:  Antimicrob Agents Chemother       Date:  2011-05-16       Impact factor: 5.191

4.  Health and economic burden of the projected obesity trends in the USA and the UK.

Authors:  Y Claire Wang; Klim McPherson; Tim Marsh; Steven L Gortmaker; Martin Brown
Journal:  Lancet       Date:  2011-08-27       Impact factor: 79.321
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.